Botulinum toxin for subacute/chronic neck pain Journal Articles

abstract

• Withdrawn due to non‐compliance with The Cochrane Collaboration’s Commercial Sponsorship Policy The editorial group responsible for this previously published document have withdrawn it from publication.

authors

• Langevin, Pierre
• Peloso, Paul Michael J
• Lowcock, Janet
• Nolan, May
• Weber, Jeff
• Gross, Anita R
• Roberts, John
• Goldsmith, Charles Harry
• Graham, Nadine
• Burnie, Stephen J
• Haines, Ted

publication date

• May 21, 2015

has subject area

• 11 Medical and Health Sciences (FoR)
• 17 Psychology and Cognitive Sciences (FoR)
• Acute Disease (MeSH)
• Botulinum Toxins, Type A (MeSH)
• Chronic Disease (MeSH)
• General & Internal Medicine (Science Metrix)
• Humans (MeSH)
• Neck Pain (MeSH)
• Neuromuscular Agents (MeSH)
• Randomized Controlled Trials as Topic (MeSH)

published in

• Cochrane Database of Systematic Reviews  Journal

keywords

• Acute Disease
• Botulinum Toxins, Type A
• Chronic Disease
• Humans
• Neck Pain
• Neuromuscular Agents
• Randomized Controlled Trials as Topic

Digital Object Identifier (DOI)

• 10.1002/14651858.cd008626.pub3

start page

• CD008626

volume

• 2015

issue

• 5